Preclinical research department is mainly responsible for preclinical efficacy research, safety evaluation and pharmacokinetics research of the company's R & D products, and is also responsible for the coordination and communication of external commissioned research.
The preclinical research department has a scientific research team with high quality and reasonable collocation. The scientific research echelon is composed of experienced managers and technicians who are proficient in experimental pharmacology, new drug pharmacology and molecular pharmacology, which ensures the smooth development of new drug preclinical pharmacology / toxicology research.
Preclinical research department has biochemical testing laboratory and cell culture room with complete facilities, and rents ordinary animal room and SPF standard animal room; Established a technical platform for preclinical pharmacodynamics research, safety evaluation and pharmacokinetics research of new drugs at cellular, molecular, immune and animal levels; A strict and standardized management system and standard operating procedures have been established.
Focusing on the company's R & D products, preclinical research department has established drug efficacy models for the treatment of tumor, neuropsychiatric, cardiovascular and cerebrovascular diseases, ophthalmology and other important diseases, and can carry out drug safety evaluation and pharmacokinetic studies.
Address: Building 7, Kangyuan medical science and Technology Park, 578 longmian Avenue, Jiangning District, Nanjing City, Jiangsu Province
Postal Code: 211100
Contact information: 025-58310595 (switchboard)